Join Zoom Meeting
https://mc-meet.zoom.us/j/92962518530?pwd=a3BLRm9HSzcybGNQQUFuNUVDb294dz09

Meeting ID: 929 6251 8530
Passcode: 927691

Rachel Anderson, M.D. – “Progressive weakness that is not GBS”

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Recognize the typical clinical presentation of inflammatory myositis
• Contrast the clinical presentation inflammatory myositis with other causes of weakness
• Select an appropriate muscle target for biopsy when evaluating for myositis
• Treat dermatomyositis

Dr. Anderson does not have any relevant financial relationships to disclose and does not intend to discuss any off-label/investigative use of Pharmaceuticals.

Kasey Hill, M.D. – “Central Pontine Myelinolysis"

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Recognize risk factors for developing central pontine myelinolysis
• Describe the time course for development of central pontine myelinolysis
• Recognize central pontine myelinolysis on CT and MRI

Dr. Hill does not have any relevant financial relationships to disclose and does not intend to discuss any off-label/investigative use of Pharmaceuticals.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.